A novel technology for protein delivery to the CNS

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$126,563.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43NS048651-01
Agency Tracking Number:
NS048651
Solicitation Year:
2004
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Small Business Information
Q THERAPEUTICS, INC.
Q THERAPEUTICS, INC., 421 WAKARA WAY, STE 201, SALT LAKE CITY, UT, 84108
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 MANI Ramaswami
 (520) 621-6624
 MANI@U.ARIZONA.EDU
Business Contact
Phone: (801) 581-0400
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The long-term objective of this research is to develop a cell-based system for delivering therapeutic gene products to brain and spinal cord. Several candidate protein pharmaceuticals exist whose use for treatment

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government